Atantares

Suzhou, China · Founded 2017 · Privately Held (backing)

Developer of precision medicines and smart diagnostic devices designed to transform disease management across hematology, cardiology, neurology and cancer. Atantares is based in Suzhou, China and was founded in 2017. Its last reported valuation was $14.5 million in Jul 2025. It has raised $28 million.

Last reported valuation

$14.5M

Oct 2026

Priced at

—

Total raised

$28.0M

Last round

—

How much has Atantares raised?

$28.0Macross 0 recorded rounds

Free account

More of Atantares with a free account

·The complete investor list: 17 names
·Watch Atantares: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Atantares investors

17 investors are on record for Atantares, including US National Science Foundation, Qiming Venture Partners, Aramco Ventures and Frees Fund.

For fundraisers

Raising for a company like Atantares?

17 investors have backed Atantares.

See all 17 investors →

Frequently asked about Atantares

How much has Atantares raised?: Atantares has raised $28.0M in total across 0 recorded funding rounds.